022 oriental renaissance: innovative, educational, natural and social sciences scientific journal volume 2, issue issn 2181-1784 Impact Factor: 947 asi factor = 7

Oriental Renaissance: Innovative, 
educational, natural and social sciences 
 
VOLUME 2 | ISSUE 5 
ISSN 2181-1784 
Scientific Journal Impact Factor
 
 SJIF 2022: 5.947 
Advanced Sciences Index Factor 
 ASI Factor = 1.7 
605 
w
www.oriens.uz
May
2022
 
16.
Segura 
J, Campo C, Gil P, Roldán C, Vigil L, Rodicio JL et al. Development of 
chronic kidney disease and cardiovascular prognosis in essential hypertensive 
patients. J Am Soc Nephrol. 2004;15(6):1616
–
1622. 
17.
Oshchepkova EV Dolgusheva IuA, Zhernakova IuV, Chazova IE
, Shal’nova 
SA, Iarovaia EB et al. The prevalence of renal dysfunction in arterial hypertension (in 
the framework of the ESSE-RF study). Sistemnye Gipertenzii = Systemic 
Hypertension. 2015;12(3):9
–
24. In Russian. 
18.
Lisowska-Myjak B. Serum and urinary biomarkers of acute kidney injury. 
Blood Purification. 2010;29(4):357
–
365. doi:10.1159/000309421 
19.
Abassi Z, Sagi O, Armaly Z, Bishara B. Neutrophil gelatinase-associated 
lipocalin (NGAL): a novel biomarker for acute kidney injury. Harefuah. 
2011;150(2):111
–
116. 
20.
Må
rtensson J, Martling CR, Bell M. Novel biomarkers of acute kidney injury 
and failure: clinical applicability. Br J Anaesth. 2012;109(6):843
–
850. 
doi:10.1093/bja/aes357 
21.
Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in 
renal disease. Clinica Chimica Acta; International Journal of Clinical Chemistry. 
2006;374(1
–
2):1
–
7. 
22.
Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR et al. 
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney 
disease. Clin J Am Soc Nephrol. 2009;4(2):337
–
344. doi:10.2215/CJN.03530708 
23.
Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv 
Chronic Kidney Dis. 2010;17(6):469
–
479. doi:10.1053/j.ackd.2010.09.002 
24.
Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R et al. 
Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic 
kidney disease in patients with obesity and metabolic syndrome. Clin J Am Soc 
Nephrol. 2011;6 (2):265
–
273. doi:10.2215/CJN.04830610 
25.
Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M. 
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in 
subjects affected by chronic kidney disease. Kidney Blood Press Res. 
2008;31(4):255
–
258. doi:10.1159/000143726 
26.
Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C et al. 
Transcriptional analysis of kidneys during repair from AKI reveals possible roles for 
NGAL and KIM
‑
1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal 
Physiol. 2010;298(6): F1472
–
F1483. doi:10.1152/ajprenal.00619.2009 

---